VVater announced a multi-year, multi-million dollar agreement to provide advanced onsite water treatment for a major food and ...
TRM Labs noted that on December 10, the United States had reportedly seized a large oil tanker off Venezuela’s coast for alleged sanctions evasion, escalating pressure on Nicolás Maduro’s regime and ...
Belgium has confirmed it will take an active role in FAST-EU, Europe’s new coordinated fast-track mechanism for multinational clinical trials. Participation will position Belgium as an operational ...
ExperienceFlow.AI, a pioneer in delivering autonomous enterprise operations and decision-making platforms, announces launch of their Superintelligence Research Laboratory. This press release features ...
Deworming drug, levamisole, is being evaluated by the European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) following concerns about its links with leukoencephalopathy.
MELBOURNE, Australia and LIÈGE, Belgium, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that it has received a positive ...
BARCELONA, Spain--(BUSINESS WIRE)--Almirall, S.A. (ALM), a global pharmaceutical company dedicated to medical dermatology announced today the successful completion of the decentralized regulatory ...
Efinaconazole is a triazole antifungal compound indicated for the treatment of onychomycosis, a persistent and difficult to treat fungal infection of the nail The completion of the decentralized ...
Abstract: In this paper, an improved approximate dynamic programming (IADP)-based limited-iterative decentralized algorithm is proposed for solving the optimal power flow (OPF) problem of networked ...
Please provide your email address to receive an email when new articles are posted on . Relfydess has received a positive decision for treatment of frown lines and crow’s feet in the European Union.
PARSIPPANY, N.J.--(BUSINESS WIRE)-- Pyros Pharmaceuticals, Inc. (Pyros or the Company), a leader in the development of enhanced specialty pharmaceuticals for rare diseases, announced today the ...
The European Medicines Agency’s safety committee has recommended that pregnant women avoid using products containing topiramate due to concerns that it may cause neurodevelopmental disorders in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results